A head-to-head study of
all three coronavirus vaccines authorized in the United States finds the
Moderna vaccine is slightly more effective than Pfizer's in real-world use at
keeping people out of the hospital, and Johnson & Johnson's Janssen vaccine
comes in third, but still provides 71% protection.
Pfizer's
vaccine provided 88% protection against hospitalization, and Moderna's was 93%
effective.
The CDC
led a nationwide study of vaccination involving more than 3,600 adults
hospitalized for Covid-19 between March and August.
They
found that the biggest difference
between the vaccine made by Moderna and Pfizer/BioNTech was driven by a decline
that started about four months after people were fully vaccinated with Pfizer's
vaccine.
"Differences in vaccine effectiveness between the Moderna and Pfizer-BioNTech vaccine might be due to higher mRNA content in the Moderna vaccine, differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna), or possible differences between groups that received each vaccine that were not accounted for in the analysis," the team wrote.
No comments:
Post a Comment